Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,830.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,772.00p
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 469,536
  • Market Cap: £4,295.37m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: John J. Castellani
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,830.00p
Change Today -9.00p
% Change -0.49 %
52 Week High 2,340.00p
52 Week Low 1,772.00p
Volume 469,536
Shares Issued 234.72m
Market Cap £4,295.37m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.23% below the market average88.23% below the market average88.23% below the market average88.23% below the market average88.23% below the market average
27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average
Price Trend
46.80% above the market average46.80% above the market average46.80% above the market average46.80% above the market average46.80% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income
1.77% above the market average1.77% above the market average1.77% above the market average1.77% above the market average1.77% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
22.70% above the market average22.70% above the market average22.70% above the market average22.70% above the market average22.70% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 11-Apr-2025

Time Volume / Share Price
15:27 0 @ 1,835.00p
15:27 0 @ 1,835.00p
15:12 0 @ 1,835.00p
15:12 0 @ 1,835.00p
15:12 0 @ 1,835.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page